{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:54:48Z","timestamp":1787162088947,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS111981"],"award-info":[{"award-number":["R01NS111981"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS111981"],"award-info":[{"award-number":["R01NS111981"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Velosano Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20847-4","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:37:47Z","timestamp":1761125867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Roshan","family":"Lodha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Muller-Greven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Buchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Qadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin Shankar","family":"Chelakkot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Burgenske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Nowacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vasmatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sani H.","family":"Kizilbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann N.","family":"Sarkaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candece L.","family":"Gladson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"20847_CR1","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp, R. et al. Effect of tumor-treating fields plus maintenance Temozolomide vs maintenance Temozolomide alone on survival in patients with glioblastoma. A randomized clinical trial. JAMA 318, 2306\u20132316 (2017).","journal-title":"JAMA"},{"key":"20847_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/neuonc\/nos273","volume":"15","author":"M Weller","year":"2013","unstructured":"Weller, M., Cloughesy, T., Perry, J. R. & Wick, W. Standards of care for treatment of recurrent glioblastoma\u2013are we there yet? Neuro-Oncol 15, 4\u201327 (2013).","journal-title":"Neuro-Oncol"},{"key":"20847_CR3","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/cancers\/6071374","volume":"16","author":"AE Barnett","year":"2024","unstructured":"Barnett, A. E. et al. MGMT methylation and differential survival impact by sex in glioblastoma. Cancers 16, 1374. https:\/\/doi.org\/10.3390\/cancers\/6071374 (2024).","journal-title":"Cancers"},{"key":"20847_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/neuronc\/noy002","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom, Q. T., Rubin, J. B., Lathia, J. D., Berens, M. E. & Barnholtz-Sloan, J. S. Females have the survival advantage in glioblastoma. Neuro-Oncology 20, 576\u2013577. https:\/\/doi.org\/10.1093\/neuronc\/noy002 (2018).","journal-title":"Neuro-Oncology"},{"key":"20847_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","volume":"14","author":"MH Cohen","year":"2009","unstructured":"Cohen, M. H., Shen, Y. L., Keegan, P. & Pazdur, R. FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist 14, 1131\u20131138 (2009).","journal-title":"Oncologist"},{"key":"20847_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1634\/theoncologist.2009-0317","volume":"15","author":"F Kazazi-Hyseni","year":"2010","unstructured":"Kazazi-Hyseni, F., Beijnen, J. H., Schellens, J. H. M.\u00a0 Bevacizumab Oncologist 15, 819\u2013825 (2010).","journal-title":"Oncologist"},{"key":"20847_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.4103\/0366-6999.161403","volume":"(Engl.) 128","author":"G Shen","year":"2015","unstructured":"Shen, G. et al. Relief effect of bevacizumab on severe edema induced by Re-irradiation in brain tumor patients. Chin. Med. J. (Engl.) 128, 2126\u20132129 (2015).","journal-title":"Chin. Med. J."},{"key":"20847_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G. & Jain, R. K. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat. Rev. Clinc Oncol. 15, 325\u2013340. https:\/\/doi.org\/10.1038\/nrclinonc.2018.29 (2018).","journal-title":"Nat. Rev. Clinc Oncol."},{"key":"20847_CR9","first-page":"9","volume":"13","author":"G Neufeld","year":"1999","unstructured":"Neufeld, G., Cohen, T., Gengrinovitch, S. & Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. Off Publ Fed. Am. Soc. Exp. Biol. 13, 9\u201322 (1999).","journal-title":"FASEB J. Off Publ Fed. Am. Soc. Exp. Biol."},{"key":"20847_CR10","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1158\/1078-0432.CCR-17-0249","volume":"23","author":"G M\u00fcller-Greven","year":"2017","unstructured":"M\u00fcller-Greven, G. et al. Macropinocytosis of bevacizumab by glioblastoma cells in the perivascular niche affects their survival. Clin. Cancer Res. 23, 7059\u20137071. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0249 (2017).","journal-title":"Clin. Cancer Res."},{"key":"20847_CR11","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/ijms19041232","volume":"19","author":"Y Itatani","year":"2018","unstructured":"Itatani, Y., Kawada, K., Yamamoto, T. & Sakai, Y. Resistance to Anti-Angiogenic therapy in Cancer\u2014Alterations to Anti-VEGF pathway. Int. J. Mol. Sci. 19, 1232 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"20847_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-19-0909","volume":"26","author":"RA Vaubel","year":"2020","unstructured":"Vaubel, R. A. et al. Genomic and phenotypic characterization of a broad panel of patient derived xenografts reflects the diversity of glioblastoma. Clin. Cancer Res. 26, 1094\u20131104. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0909 (2020).","journal-title":"Clin. Cancer Res."},{"key":"20847_CR13","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"20847_CR14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Towards Understanding the origin and evolution of cellular organism. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"20847_CR15","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Soto, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"20847_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acid Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acid Res."},{"key":"20847_CR17","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1038\/s41467-022-31981-2","volume":"13","author":"E Bae","year":"2022","unstructured":"Bae, E. et al. Integrin \u03b13\u03b21 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis. Nat. Commun. 13, 4268. https:\/\/doi.org\/10.1038\/s41467-022-31981-2 (2022).","journal-title":"Nat. Commun."},{"key":"20847_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","volume":"98","author":"DK Meyerholz","year":"2018","unstructured":"Meyerholz, D. K. & Beck, A. P. Principles and approaches for reproducible scoring of tissue stains in research. Lab. Invest. 98, 844\u2013855. https:\/\/doi.org\/10.1038\/s41374-018-0057-0 (2018).","journal-title":"Lab. Invest."},{"key":"20847_CR19","first-page":"157","volume":"50","author":"KX Pearson","year":"1900","unstructured":"Pearson, K. X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Lond. Edinb. Dublin Philos. Mag J. Sci. 50, 157\u2013175 (1900).","journal-title":"Mag J. Sci."},{"key":"20847_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov"},{"key":"20847_CR21","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"20847_CR22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462\u2013477 (2013).","journal-title":"Cell"},{"key":"20847_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","unstructured":"Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","journal-title":"Nature"},{"key":"20847_CR24","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn, F. S. et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell 185, 2184\u20132199 (2022).","journal-title":"Cell"},{"key":"20847_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1158\/0008-5472.CAN-23-2093","volume":"84","author":"TM Malta","year":"2024","unstructured":"Malta, T. M. et al. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Res. 84, 741\u2013756. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2093 (2024).","journal-title":"Cancer Res."},{"key":"20847_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell. Syst. 1, 417\u2013425 (2015).","journal-title":"Cell. Syst."},{"key":"20847_CR27","doi-asserted-by":"crossref","unstructured":"Sun, J. Z. et al. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma. Dis. Markers 2021, 6680883 (2021).","DOI":"10.1155\/2021\/6680883"},{"key":"20847_CR28","doi-asserted-by":"publisher","first-page":"593234","DOI":"10.3389\/fcell.2020.593234","volume":"8","author":"Z Dong","year":"2021","unstructured":"Dong, Z. et al. Microtubule severing protein Fignl2 contributes to endothelial and neuronal branching in zebrafish development. Front. Cell. Dev. Biol. 8, 593234 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"20847_CR29","doi-asserted-by":"publisher","first-page":"11270","DOI":"10.1038\/s41598-020-67743-7","volume":"10","author":"N Gonz\u00e1lez-Garc\u00eda","year":"2020","unstructured":"Gonz\u00e1lez-Garc\u00eda, N. et al. Multivariate analysis reveals differentially expressed genes among distinct subtypes of diffuse astrocytic gliomas: diagnostic implications. Sci. Rep. 10, 11270 (2020).","journal-title":"Sci. Rep."},{"key":"20847_CR30","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1101\/gad.1024602","volume":"16","author":"TA Baudino","year":"2002","unstructured":"Baudino, T. A. et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16, 2530\u20132543 (2002).","journal-title":"Genes Dev."},{"key":"20847_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","volume":"4","author":"J Karar","year":"2011","unstructured":"Karar, J. & Maity, A. PI3K\/AKT\/mTOR pathway in angiogenesis. Front. Mol. Neurosci. 4, 51 (2011).","journal-title":"Front. Mol. Neurosci."},{"key":"20847_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/1541-7786.MCR-08-0577","volume":"7","author":"Y Matsuo","year":"2009","unstructured":"Matsuo, Y. et al. K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through Mitogen-Activated protein kinase signaling pathways. Mol. Cancer Res. 7, 799\u2013808 (2009).","journal-title":"Mol. Cancer Res."},{"key":"20847_CR33","unstructured":"Angiogenesis Gene Ontology Term (GO:0001525). http:\/\/www.informatics.jax.org\/vocab\/gene_ontology\/GO:0001525"},{"key":"20847_CR34","doi-asserted-by":"publisher","first-page":"20021","DOI":"10.1074\/jbc.273.32.20021","volume":"273","author":"C Carrasco-Serrano","year":"1998","unstructured":"Carrasco-Serrano, C., Campos-Caro, A., Viniegra, S., Ballesta, J. J. & Criado, M. GC- and E-box motifs as regulatory elements in the proximal promoter region of the neuronal nicotinic receptor \u03b17 subunit gene. J. Biol. Chem. 273, 20021\u201320028 (1998).","journal-title":"J. Biol. Chem."},{"key":"20847_CR35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1046\/j.1471-4159.2000.0740932.x","volume":"74","author":"C Carrasco-Serrano","year":"2000","unstructured":"Carrasco-Serrano, C., Viniegra, S., Ballesta, J. J. & Criado, M. Phorbol ester activation of the neuronal nicotinic acetylcholine receptor \u03b17 subunit gene: involvement of transcription factor Egr-1. J. Neurochem. 74, 932\u2013939 (2000).","journal-title":"J. Neurochem"},{"key":"20847_CR36","doi-asserted-by":"publisher","first-page":"16749","DOI":"10.1074\/jbc.M009712200","volume":"276","author":"U Nagavarapu","year":"2001","unstructured":"Nagavarapu, U., Danthi, S. & Boyd, T. Characterization of a rat neuronal nicotinic acetylcholine receptor \u03b17 promoter. J. Biol. Chem. 276, 16749\u201316758 (2001).","journal-title":"J. Biol. Chem."},{"key":"20847_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cellsig.2013.12.019","volume":"26","author":"SS Hahn","year":"2014","unstructured":"Hahn, S. S., Tang, Q., Zheng, F., Zhao, S. & Wu, J. J. GW1929 inhibits \u03b17 nAChR expression through PPARgamma-independent activation of p38MAPK and inactivation of PI3-K\/mTOR: the role of Egr1. Cell. Signal. 26, 730\u2013739 (2014).","journal-title":"Cell. Signal."},{"key":"20847_CR38","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkt997","volume":"42","author":"A Mathelier","year":"2014","unstructured":"Mathelier, A. et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res. 42, D142\u2013147 (2014).","journal-title":"Nucleic Acids Res."},{"key":"20847_CR39","doi-asserted-by":"publisher","first-page":"D91","DOI":"10.1093\/nar\/gkh012","volume":"32","author":"A Sandelin","year":"2004","unstructured":"Sandelin, A., Alkema, W., Engstr\u00f6m, P., Wasserman, W. W. & Lenhard, B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91\u201394 (2004).","journal-title":"Nucleic Acids Res."},{"key":"20847_CR40","doi-asserted-by":"publisher","first-page":"10342","DOI":"10.1038\/s41598-021-89754-8","volume":"11","author":"JY Lee","year":"2021","unstructured":"Lee, J. Y. et al. EGR1 as a potential marker of prognosis in extranodal NK\/T-cell lymphoma. Sci. Rep. 11, 10342 (2021).","journal-title":"Sci. Rep."},{"key":"20847_CR41","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinforma Oxf. Engl. 26, 2438\u20132444 (2010).","journal-title":"Bioinforma Oxf. Engl."},{"key":"20847_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0079-6603(08)60815-6","volume":"50","author":"A Gashler","year":"1995","unstructured":"Gashler, A. & Sukhatme, V. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucl. Acid Res. 50, 191\u2013224 (1995).","journal-title":"Prog Nucl. Acid Res."},{"key":"20847_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/01.RES.81.4.457","volume":"81","author":"LM Khachigian","year":"1997","unstructured":"Khachigian, L. M. & Collins, T. Inducible expression of Egr-1-dependent genes: a paradigm of transcriptional activation in vascular endothelium. Circ. Res. 81, 457\u2013461 (1997).","journal-title":"Circ. Res."},{"key":"20847_CR44","doi-asserted-by":"publisher","first-page":"100839","DOI":"10.1016\/j.neo.2022.100839","volume":"34","author":"L Yin","year":"2022","unstructured":"Yin, L., Zhang, J. & Sun, Y. Early growth response-1 is a new substrate of the GSK3\u03b2-FBXW7 axis. Neoplasia 34, 100839. https:\/\/doi.org\/10.1016\/j.neo.2022.100839 (2022).","journal-title":"Neoplasia"},{"key":"20847_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12935-019-0819-9","volume":"19","author":"S Yu","year":"2019","unstructured":"Yu, S. et al. Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner. Cancer Cell. Int. 19, 116. https:\/\/doi.org\/10.1186\/s12935-019-0819-9 (2019).","journal-title":"Cancer Cell. Int."},{"key":"20847_CR46","doi-asserted-by":"publisher","first-page":"a005090","DOI":"10.1101\/cshperspect.a005090","volume":"3","author":"DR Senger","year":"2011","unstructured":"Senger, D. R., Davis, G. E.  Angiogenesis Cold Spring Harb Perspect. Biol. 3, a005090 https:\/\/doi.org\/10.1101\/cshperspect.a005090 (2011).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"20847_CR47","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/ijms21051664","volume":"21","author":"E Havis","year":"2020","unstructured":"Havis, E. & Duprez, D. EGR1 transcription factor is a multifaceted regulator of matrix production in tendons and other connective tissue. Int. J. Mol. Sci. 21, 1664. https:\/\/doi.org\/10.3390\/ijms21051664 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"20847_CR48","doi-asserted-by":"crossref","unstructured":"Wang, B. et al. The role of the transcription factor EGR1 in cancer. Front. Oncol. 11 (2021).","DOI":"10.3389\/fonc.2021.642547"},{"key":"20847_CR49","doi-asserted-by":"publisher","first-page":"9285","DOI":"10.1038\/s41598-020-66235","volume":"10","author":"AM Knudsen","year":"2020","unstructured":"Knudsen, A. M. et al. Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas. Sci. Rep. 10, 9285. https:\/\/doi.org\/10.1038\/s41598-020-66235 (2020).","journal-title":"Sci. Rep."},{"key":"20847_CR50","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1074\/jbc.M116.720698","volume":"291","author":"N Sakakini","year":"2016","unstructured":"Sakakini, N. et al. A positive feed-forward loop associating EGR1 and PDGFA promotes proliferation and self-renewal in glioblastoma stem cells. J. Biol. Chem. 291, 10684\u201310699 (2016).","journal-title":"J. Biol. Chem."},{"key":"20847_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13046-017-0656-4","volume":"36","author":"DG Chen","year":"2017","unstructured":"Chen, D. G. et al. Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter. J. Exp. Clin. Cancer Res. 36, 186. https:\/\/doi.org\/10.1186\/s13046-017-0656-4 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"20847_CR52","doi-asserted-by":"publisher","first-page":"9934","DOI":"10.1158\/0008-5472.CAN-05-1830","volume":"65","author":"D Xiao","year":"2005","unstructured":"Xiao, D., Chinnappan, D., Pestell, R., Albanese, C. & Weber, H. C. Bombesin regulates Cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer. Cancer Res. 65, 9934\u20139942 (2005).","journal-title":"Cancer Res."},{"key":"20847_CR53","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12885-017-3251-3","volume":"17","author":"T Urup","year":"2017","unstructured":"Urup, T. et al. Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients. BMC Cancer. 17, 278. https:\/\/doi.org\/10.1186\/s12885-017-3251-3 (2017).","journal-title":"BMC Cancer"},{"key":"20847_CR54","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nm905","volume":"9","author":"RG Fahmy","year":"2003","unstructured":"Fahmy, R. G., Dass, C. R., Sun, L. Q., Chesterman, C. N. & Khachigian, L. M. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat. Med. 9, 1026\u20131032 (2003).","journal-title":"Nat. Med."},{"key":"20847_CR55","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.lfs.2012.06.032","volume":"91","author":"J Lee","year":"2012","unstructured":"Lee, J. & Cooke, J. P. Nicotine and pathological angiogenesis. Life Sci. 91, 1058\u20131064 (2012).","journal-title":"Life Sci."},{"key":"20847_CR56","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/IAE.0b013e31823496b8","volume":"32","author":"SJ Davis","year":"2012","unstructured":"Davis, S. J. et al. The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration. Retina Phila. Pa. 32, 1171\u20131180 (2012).","journal-title":"Retina Phila. Pa."},{"key":"20847_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10456-011-9246-9","volume":"15","author":"KC Brown","year":"2012","unstructured":"Brown, K. C. et al. MG624, an \u03b17-nAChR antagonist, inhibits angiogenesis via the Egr-1\/FGF2 pathway. Angiogenesis 15, 99\u2013114 (2012).","journal-title":"Angiogenesis"},{"key":"20847_CR58","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/bjp.2008.185","volume":"154","author":"I Wessler","year":"2008","unstructured":"Wessler, I. & Kirkpatrick, C. J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol. 154, 1558\u20131571 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"20847_CR59","doi-asserted-by":"publisher","first-page":"105336","DOI":"10.1016\/j.phrs.2020.105336","volume":"163","author":"S Pucci","year":"2021","unstructured":"Pucci, S. et al. Choline and nicotine increase glioblastoma cell proliferation by binding and activating \u03b17- and \u03b19- containing nicotinic receptors. Pharmacol. Res. 163, 105336 (2021).","journal-title":"Pharmacol. Res."},{"key":"20847_CR60","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1113\/JP275101","volume":"596","author":"C Bouzat","year":"2018","unstructured":"Bouzat, C., Lasala, M., Nielsen, B. E., Corradi, J. & Esandi, M. Del C. Molecular function of \u03b17 nicotinic receptors as drug targets. J. Physiol. 596, 1847\u20131861 (2018).","journal-title":"J. Physiol."},{"key":"20847_CR61","doi-asserted-by":"crossref","unstructured":"Thompson, E. G. & Sontheimer, H. Acetylcholine receptor activation as a modulator of glioblastoma invasion. Cells 8(10) (2019).","DOI":"10.3390\/cells8101203"},{"key":"20847_CR62","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.peptides.2011.05.022","volume":"32","author":"K Kuwasako","year":"2011","unstructured":"Kuwasako, K. et al. Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 32, 1540\u20131550 (2011).","journal-title":"Peptides"},{"key":"20847_CR63","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0196-9781(01)00513-7","volume":"22","author":"T Eto","year":"2001","unstructured":"Eto, T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 22, 1693\u20131711 (2001).","journal-title":"Peptides"},{"key":"20847_CR64","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1161\/hc4101.097111","volume":"104","author":"T Shindo","year":"2001","unstructured":"Shindo, T. et al. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104, 1964\u20131971 (2001).","journal-title":"Circulation"},{"key":"20847_CR65","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.peptides.2005.02.017","volume":"26","author":"D Ribatti","year":"2005","unstructured":"Ribatti, D., Nico, B., Spinazzi, R., Vacca, A. & Nussdorfer, G. G. The role of adrenomedullin in angiogenesis. Peptides 26, 1670\u20131675 (2005).","journal-title":"Peptides"},{"key":"20847_CR66","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0002-9440(10)62555-2","volume":"160","author":"L Ouafik","year":"2002","unstructured":"Ouafik, L. et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am. J. Pathol. 160, 1279\u20131292 (2002).","journal-title":"Am. J. Pathol."},{"key":"20847_CR67","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1096\/fj.08-127852","volume":"23","author":"I Kaafarani","year":"2009","unstructured":"Kaafarani, I. et al. Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice. FASEB J. 23, 3424\u20133435 (2009).","journal-title":"FASEB J."},{"key":"20847_CR68","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3174\/ajnr.A2917","volume":"33","author":"WB Pope","year":"2012","unstructured":"Pope, W. B. et al. Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival. AJNR Am. J. Neuroradiol. 33, 1059\u20131064. https:\/\/doi.org\/10.3174\/ajnr.A2917 (2012).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"20847_CR69","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/cam4.1439","volume":"7","author":"SW Choi","year":"2018","unstructured":"Choi, S. W. et al. Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma. Cancer Med. 7, 1774\u20131783. https:\/\/doi.org\/10.1002\/cam4.1439 (2018).","journal-title":"Cancer Med."},{"key":"20847_CR70","doi-asserted-by":"publisher","unstructured":"Lin, H. et al. Identification of COL6A1 as the key gene associated with antivascular endothelial growth factor therapy in glioblastoma multiforme. Genetic Test. Mol. Biomarkers. 25 https:\/\/doi.org\/10.1089\/gtmb2020.0279 (2021).","DOI":"10.1089\/gtmb2020.0279"},{"key":"20847_CR71","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.18632\/aging.204834","volume":"15","author":"G Yao","year":"2023","unstructured":"Yao, G., Deng, L., Long, X., Zhou, Y. & Zhou, X. An integrated bioinformatic investigation of focal adhesion-related genes in glioma followed by preliminary validation of COL1A2 in tumorigenesis. Aging 15, 6228\u20136254. https:\/\/doi.org\/10.18632\/aging.204834 (2023).","journal-title":"Aging"},{"key":"20847_CR72","doi-asserted-by":"publisher","first-page":"70494","DOI":"10.18632\/oncotarget.12038","volume":"7","author":"YF Gao","year":"2016","unstructured":"Gao, Y. F. et al. COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value. Oncotarget 7, 70494\u201370503 (2016).","journal-title":"Oncotarget"},{"key":"20847_CR73","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/1541-7786.MCR-07-0113","volume":"5","author":"M Ferletta","year":"2007","unstructured":"Ferletta, M., Uhrbom, L., Olofsson, T., Pont\u00e9n, F. & Westermark, B. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B\u2013induced gliomagenesis. Mol. Cancer Res. 5, 891\u2013897 (2007).","journal-title":"Mol. Cancer Res."},{"key":"20847_CR74","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/s41467-020-20225-w","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype. Nat. Commun. 11, 6434 (2020).","journal-title":"Nat. Commun."},{"key":"20847_CR75","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11060-019-03102-5","volume":"142","author":"KE Hovinga","year":"2019","unstructured":"Hovinga, K. E. et al. EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma. J. Neurooncol. 142, 337\u2013345 (2019).","journal-title":"J. Neurooncol"},{"key":"20847_CR76","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s11307-018-1289-5","volume":"21","author":"A Stadlbauer","year":"2019","unstructured":"Stadlbauer, A. et al. Predicting glioblastoma response to bevacizumab through MRI biomarkers of the tumor microenvironment. Mol. Imaging Biol. 21, 747\u2013757 (2019).","journal-title":"Mol. Imaging Biol."},{"key":"20847_CR77","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1750-3639.2008.00175.x","volume":"19","author":"M Mittelbronn","year":"2009","unstructured":"Mittelbronn, M. et al. EGR1 is regulated by N-Methyl-D-Aspartate-receptor stimulation and associated with patient survival in human high grade Astrocytomas. Brain Pathol. 19, 195\u2013204 (2009).","journal-title":"Brain Pathol."},{"key":"20847_CR78","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1038\/s41467-019-11905-3","volume":"10","author":"Z Sun","year":"2019","unstructured":"Sun, Z. et al. EGR1 recruits TET1 to shape the brain methylome during development and upon neuronal activity Nat. Commun 10, 3892. https:\/\/doi.org\/10.1038\/s41467-019-11905-3 (2019).","journal-title":"Commun"},{"key":"20847_CR79","doi-asserted-by":"publisher","unstructured":"Rocks, D. et al. Egr1 is a sex-specific regulator of neuronal chromatin, synaptic plasticity and behavior. BioRxiv 21 https:\/\/doi.org\/10.1101\/2023.12.20.572697 (2023).","DOI":"10.1101\/2023.12.20.572697"},{"key":"20847_CR80","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1038\/onc.2008.247","volume":"27","author":"A Carracedo","year":"2008","unstructured":"Carracedo, A. & Pandolfi, P. P. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27, 5527\u20135541 (2008).","journal-title":"Oncogene"},{"key":"20847_CR81","doi-asserted-by":"publisher","unstructured":"Esteve, P-O. et al. A methylation and phosphorylation switch between an adjacent lysine and Serine determines human DNMT1 stability. Nat. Struct. Mol. Biol. 18 https:\/\/doi.org\/10.1038\/nsmb.1939 (2011).","DOI":"10.1038\/nsmb.1939"},{"key":"20847_CR82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcancer.2019.04.001","volume":"59","author":"Q Yang","year":"2019","unstructured":"Yang, Q., Jiang, W. & Hou, P. Emerging role of PI3K\/Akt in tumor-related epigenetic regulation. Sem Cancer Biol. 59, 112\u2013124. https:\/\/doi.org\/10.1016\/j.semcancer.2019.04.001 (2019).","journal-title":"Sem Cancer Biol."},{"key":"20847_CR83","doi-asserted-by":"publisher","first-page":"105160","DOI":"10.1016\/j.archoralbio.2021.105160","volume":"128","author":"R Tian","year":"2021","unstructured":"Tian, R. et al. DNA methyltransferase1 inhibits 06-methylguanine-DNAmethyl-transferase-mdediated cell growth and metastasis of hypopharyngeal squamous carcinoma. Archives Oral Biol. 128, 105160. https:\/\/doi.org\/10.1016\/j.archoralbio.2021.105160 (2021).","journal-title":"Archives Oral Biol."},{"key":"20847_CR84","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.3390\/ijms22094999","volume":"22","author":"HN Lee","year":"2021","unstructured":"Lee, H. N., Jeong, M. S. & Jang, S. B. Molecular characteristics of amyloid precursor protein (APP) and its effects in cancer. Int. J. Mol. Sci. 22, 4999 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"20847_CR85","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","volume":"275","author":"HY Wang","year":"2000","unstructured":"Wang, H. Y. et al. beta-Amyloid(1\u201342) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for alzheimer\u2019s disease pathology. J. Biol. Chem. 275, 5626\u20135632 (2000).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20847-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20847-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20847-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:03:08Z","timestamp":1761130988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20847-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20847"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20847-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36860"}}